Press Releases :: NeoGenomics, Inc. (NEO)

NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types

NeoGenomics to Participate in Upcoming Investor Conferences

Menu

Test Search

Year

Category

Oct 30, 2018 7:00 am EDT

NeoGenomics Reports 17% Revenue Growth to Record $69 Million

Oct 23, 2018 7:00 am EDT

NeoGenomics Signs Definitive Agreement to Acquire Genoptix

Oct 1, 2018 7:00 am EDT

NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018

Sep 24, 2018 7:00 am EDT

NeoGenomics Announces Participation in NCI-MATCH Clinical Trial

Sep 12, 2018 8:14 am EDT

NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

Aug 9, 2018 8:40 pm EDT

NeoGenomics Announces Pricing on Public Offering of Common Stock

Aug 6, 2018 4:19 pm EDT

NeoGenomics Announces Proposed Public Offering of Common Stock

Jul 24, 2018 7:00 am EDT

NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

Jul 2, 2018 4:05 pm EDT

NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018

Jun 25, 2018 4:05 pm EDT

NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock